India’s Transformation into a Global Health Powerhouse — A New Era in Public Health

New Delhi, 01 Mar 2026: India is rapidly emerging as a leading global force in healthcare — not just in delivering affordable services domestically, but also in contributing to worldwide health security, medical innovation, and capacity building.

A Press Information Bureau release highlights how strategic government leadership, large-scale public health programmes, cutting-edge technology and expanded infrastructure are positioning India as a global health powerhouse. The transformation is rooted in universal health coverage, a booming pharmaceutical industry, digital healthcare, and innovation.

Universal Healthcare: The Ayushman Bharat Framework

At the centre of India’s health transformation is the Ayushman Bharat scheme — a multi-pronged effort to bring quality care to every citizen.

Under this umbrella, key programmes include:

• Pradhan Mantri Jan Arogya Yojana (PM-JAY): The world’s largest government-funded health assurance scheme providing up to ₹5 lakh per year in secondary and tertiary care for low-income families; it currently covers roughly 120 million families, with over 434 million Ayushman cards issued.
• Ayushman Arogya Mandirs (AAMs): More than 1,84,235 primary health care outlets across urban, rural and tribal areas are operational, delivering preventive and promotive health services.
• Preventive Screening Drives: By October 2025, millions were screened for major non-communicable diseases — including 401 million hypertension screenings and 399 million diabetes screenings — showing the scale of preventive outreach.

The programme has also reported 426.6 million teleconsultations through digital health platforms, helping extend care to remote regions.

Fortifying the Health System: Infrastructure and Innovation

To boost preparedness and access, the Government launched the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) in 2021. Over a five-year period (2021–26), the government has approved ₹32,928.82 crore (~US $3.6 billion) for strengthening health infrastructure nationwide. This includes:

• 9,519 building-less AAMs
• 5,456 urban-based AAMs
• 2,151 Block Public Health Units
• 744 Integrated Public Health Labs
• 622 Critical Care Blocks in district hospitals and medical colleges

A robust digital health ecosystem under the Ayushman Bharat Digital Mission (ABDM) supports this infrastructure, with more than 863 million ABHA health IDs issued to date. These unique digital records allow efficient storage, retrieval and secure teleconsultation — transforming health access and record-keeping across the nation.

India also operates one of the world’s largest digital mental health initiatives, with 53 support cells across all states and union territories handling over 3.28 million counselling sessions in multiple languages.

Expanding Coverage Through Vaccination and Outreach Programmes

India’s health strategy continues to emphasise immunisation at scale. Under the Universal Immunisation Programme (UIP), roughly 26.7 million newborns and 29 million pregnant women receive vaccination annually at no cost — one of the largest public immunisation efforts globally.

Session delivery is boosted by over 1.03 million community health workers (ASHAs), who facilitated more than 13 million immunisation sessions nationwide.

In a historic public health milestone, India launched a nationwide HPV vaccination programme on 28 Feb 2026, providing the Gardasil-4 vaccine free to approximately 11.5 million adolescent girls, marking a major step in cervical cancer prevention.

India as the ‘Pharmacy of the World’ and Bioeconomy Leader

On the global stage, India’s pharmaceutical and biopharmaceutical sectors are playing a pivotal role:

• India supplies an estimated 20 % of global generic medicines and accounts for around 55–60 % of vaccines procured by UNICEF.
• According to industry data, the Indian pharma market — valued at around US $50 billion (2023–24) — is projected to grow to US $130 billion by 2030, with exports to over 200 countries. India also remains the world’s largest vaccine manufacturer by volume.
• India’s bioeconomy — including biotech and health technology sectors — is set to reach US $300 billion by 2030, driven by strong startup growth and innovation.

This “Pharmacy of the World” status was notably evident during the COVID-19 pandemic, when India supplied vaccines to dozens of countries under initiatives such as Vaccine Maitri.

Beyond Numbers: What This Means for India and the World

From providing affordable healthcare to millions at home, to distributing vaccines and medicines around the world, India’s health agenda is now both a national and global endeavour. Despite being a lower-middle-income country a few decades ago, India’s health architecture today combines scale, digital reach, clinical innovation, and strategic manufacturing — a rare blend that few nations match.

As India works toward its 2047 development goals, its expanding healthcare footprint — domestically and internationally — underscores a new chapter: one where accessible care, medical technology, and public health resilience define not just national progress, but global impact.

---

Source: PIB

---